G B. Mancini-John

828 W. 10th Avenue
Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

VIEWPOINT: Which Patient Is a VESALIUS-CV Patient? Rethinking Primary and Secondary Prevention.

VIEWPOINT: Which Patient Is a VESALIUS-CV Patient? Rethinking Primary and Secondary Prevention.

Journal: The Canadian journal of cardiology

Published: July 21, 2026

Effect of Evolocumab on Grafts Post-Coronary Artery Bypass Surgery: Post-Hoc Analysis of Newton-CABG CardioLink-5.

Effect of Evolocumab on Grafts Post-Coronary Artery Bypass Surgery: Post-Hoc Analysis of Newton-CABG CardioLink-5.

Journal: JACC. Advances

Published: April 10, 2026

Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotype.

Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotype.

Journal: Atherosclerosis

Published: December 15, 2025

Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: An international collaboration.

Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: An international collaboration.

Journal: Atherosclerosis

Published: October 08, 2025

Plaque remodelling as a surrogate for major adverse cardiac events.

Plaque remodelling as a surrogate for major adverse cardiac events.

Journal: Atherosclerosis

Published: July 23, 2025

Begin With The End In Mind: What 75-Year Follow-Up of Young, Healthy Individuals Can Teach Us About Prevention of Cardiovascular Disease.

Begin With The End In Mind: What 75-Year Follow-Up of Young, Healthy Individuals Can Teach Us About Prevention of Cardiovascular Disease.

Journal: The Canadian journal of cardiology

Published: July 03, 2025

Traditional and Novel Markers: Target of Treatment vs Marker of Risk.

Traditional and Novel Markers: Target of Treatment vs Marker of Risk.

Journal: The Canadian journal of cardiology

Published: February 16, 2024

Effects of adaptive or fixed thresholds and different platforms on the assessment of plaque characteristics using coronary computed tomography angiography.

Effects of adaptive or fixed thresholds and different platforms on the assessment of plaque characteristics using coronary computed tomography angiography.

Journal: Journal of cardiovascular computed tomography

Published: November 16, 2023

LDL-C Estimation Equation Performance Characteristics Highlight Value of Preferentially Using Non-HDL Cholesterol or Directly Measured Apolipoprotein B.

LDL-C Estimation Equation Performance Characteristics Highlight Value of Preferentially Using Non-HDL Cholesterol or Directly Measured Apolipoprotein B.

Journal: The Canadian journal of cardiology

Published: March 01, 2023

2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults.

2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults.

Journal: The Canadian journal of cardiology

Published: March 16, 2022

Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials.

Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials.

Journal: Journal of clinical lipidology

Published: November 24, 2021

CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial.

CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial.

Journal: JACC. Cardiovascular imaging

Published: March 05, 2020

Showing 1-12 of 37

Last Updated: 09/26/2026